|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.7 EUR | 0.00% |
|
+0.35% | -7.42% |
| Apr. 19 | Biotest Launches New Plasma Collection Center in Germany | MT |
| Mar. 28 | Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Biotest Aktiengesellschaft raised earnings guidance for the year 2023. Biotest AG had forecasted in April 2023 an EBIT that may possibly exceed EUR 100 million. Based on current information, the Executive Board expects EBIT for fiscal 2023 to be in the order of EUR 130 - 170 million.
The Executive Board continues to aim for a mid-single-digit percentage increase in revenue for the 2023 financial year compared to 2022, excluding revenue from the technology transfer and licensing agreement.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.42% | 1.48B | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
BIOTEST AG 
